health insurance glp 1 coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. Read more: https://thehill.com/policy/healthcare/5972729-glp-1-insurance-change-impacts-millions-of Costly GLP-1 Drugs are Rarely

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Dietitians explain why you should think twice before following the trendy plan.

2 oz / 57g

Finally, a weight loss approach that works with your biology.

This time, the discussion centered around GLP-1 therapies and the rapidly expanding field of incretin-based medicine.

You can also join us at our website, GLP-1Hub.com for articles, meal plans, and other useful resources